You must be 18 years or older to access this website.
All products are sold strictly for laboratory and research purposes only. By entering, you confirm you are a qualified researcher.
Research Intelligence
Stay informed with the latest developments in peptide research, laboratory best practices, and UK regulatory updates from our expert team.
Retatrutide and MOTS-c are very different molecules. One is an investigational triple hormone receptor agonist; the other a naturally occurring mitochondrial-derived peptide. Here is why researchers are interested in each, and why they should not be viewed as two versions of the same weight-management peptide.
Read More
Not all peptides are compatible. Learn why mixing peptides without proper validation can reduce effectiveness, affect stability and increase the risk of unwanted reactions.
Read More
A practical guide to storing, handling, reconstituting, and aliquoting research peptides correctly to preserve biological activity and ensure reproducible experimental results.
Read MoreSeparating facts from headlines—and what the recent FDA Pharmacy Compounding Advisory Committee vote on seven peptides could mean for patients, clinicians, and the future of peptide medicine.
Read MoreLearn about Retatrutide dosage, titration schedules, expected weight loss results, common side effects and safety considerations. A comprehensive guide based on current clinical research.
Read MoreDiscover what Tesamorelin is, how it stimulates natural growth hormone production, its role in reducing visceral fat, improving body composition and supporting metabolic health.
Read MoreDiscover what NAD+ is, why it is essential for cellular energy and healthy ageing, and what the latest scientific research says about this important coenzyme.
Read More
MOTS-c, the mitochondrial-derived peptide, has entered Phase 2a human clinical testing for prediabetes and obesity. Here's what the NCT07505745 trial means for metabolic research.
Read More
An in-depth examination of Semax and Selank — their neurotrophic and anxiolytic mechanisms, key research findings, and relevance for laboratory study in 2026.
Read More
Understanding the legal framework surrounding research peptides in the UK is essential for any laboratory. This guide covers MHRA classifications, importation rules, and compliance requirements for researchers.
Read MoreBPC-157 and TB-500 are among the most studied peptides in preclinical muscle recovery research. This article compares their mechanisms, research profiles, and how they are studied in laboratory models of injury.
Read More
Tirzepatide and semaglutide represent two of the most studied metabolic peptides in obesity research. This article compares their receptor targets, mechanisms, and preclinical data relevant to laboratory investigation.
Read More
In preclinical tissue repair research, the combination of BPC-157 and TB-500 — known as the 'Wolverine Stack' — is widely studied for its complementary mechanisms across angiogenesis, cell migration, and soft tissue regeneration.
Read MoreRetatrutide (LY3437943) has delivered some of the strongest weight loss results in metabolic research history. This 2026 update reviews Phase 2 and Phase 3 TRIUMPH programme data, mechanism of action, and research implications.
Read More
A 2026 update on the latest preclinical advances across tissue repair, metabolic regulation, growth hormone signalling, immune modulation, and longevity peptide research. Includes PubMed-referenced citations.
Read MoreA curated synthesis of the latest preclinical and translational findings across key peptide research areas — tissue repair, metabolic pathways, growth hormone, immune modulation, and longevity. Includes PubMed-referenced citations.
Read More
A research-focused overview of key peptides studied for longevity and anti-aging — including Epitalon, CJC-1295/Ipamorelin, Thymosin Alpha 1, BPC-157, and AOD-9604. Covers hallmarks of aging mechanisms with PubMed-referenced citations.
Read More
A research-focused overview of Thymosin Alpha 1 (Tα1) — the thymic peptide studied for T-cell maturation, immune reconstitution, NK cell activity, and cytokine modulation. Includes PubMed-referenced citations.
Read More
A research-focused overview of Semaglutide — the long-acting GLP-1 receptor agonist studied for incretin biology, appetite regulation, glucose homeostasis, and body weight management. Includes PubMed-referenced citations.
Read MoreA research-focused overview of AOD-9604 — the lipolytic fragment of human growth hormone studied for selective fat metabolism, lipolysis pathways, and metabolic syndrome models. Includes PubMed-referenced citations.
Read MoreAn in-depth laboratory research comparison of CJC-1295 and Ipamorelin — mechanisms, GH release patterns, synergistic use, and key findings. Includes PubMed-referenced citations.
Read More
A research-focused guide examining typical onset and duration timelines for the most commonly studied peptides, including BPC-157, TB-500, Semaglutide, and Tirzepatide. Includes PubMed-referenced citations.
Read More
An in-depth research comparison of Tirzepatide and Semaglutide — receptor targets, metabolic mechanisms, and head-to-head findings for UK laboratory researchers. Includes PubMed-referenced citations.
Read More
An in-depth research comparison of BPC-157 and TB-500 — mechanisms, preclinical findings, and head-to-head data for UK laboratory researchers. Includes PubMed-referenced citations.
Read More
Navigate the regulatory landscape for purchasing and using research peptides in the United Kingdom.
Read More
